Shares of Arm Holdings (NASDAQ: ARM) have given up most of their IPO gains as investors cool on the company's long-term prospects. While Arm-based chips are dominant in the smartphone, consumer electronics, and embedded markets, Arm's growth will need to be driven by markets where the company has less of a presence. The cloud data center is one such market.
Simple gestures could be all it takes to alter the colour of your clothes in the future, according to a research team that has developed a colour-changing textile embedded with a tiny camera and making use of artificial intelligence. The technology could help reduce waste by giving people more colour choices for an item of clothing, says Hong Kong-based Laboratory for Artificial Intelligence in Design (AiDLab). Professor Jeanne Tan, who works at Polytechnic University's School of Fashion and Textiles and heads the research team, notes the POFs are made of polymethyl methacrylate which is recyclable and the structure of the textile enables easy separation of POFs from yarns for recycling.
FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Name of exempt principal trader:Investec Bank plc(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeabrdn European Logistics Income plc(c) Name of the party to the offer with which exempt principal trader i
Former prime minister arrived at the inquiry venue three hours early as he faces questions on UK’s late lockdown
Both NBI-1117569 (an M4-preferring agonist) and NBI-1117567 (an M1-preferring agonist) are investigational, oral, muscarinic agonists discovered by Sosei Heptares that may have the potential to treat neurological and neuropsychiatric conditionsNeurocrine Biosciences confirmed a Phase 1 clinical study of NBI-1117569 has started and a Phase 1 study of NBI-1117567 will be initiated in 2024 Tokyo, Japan and Cambridge, UK, 6 December 2023 – Sosei Group Corporation (“the Company”; TSE: 4565), notes it
TOKYO, December 06, 2023--Launch of APO Productivity Databook 2023
New tool automates the process of dilution application accurately and fairly to existing shareholders and protects the fund’s holdings.London, Dec. 06, 2023 (GLOBE NEWSWIRE) -- big xyt, the independent provider of smart data and analytics solutions to the global trading and investment community, today announced the launch of its Portfolio Liquidity Analysis solution. Developed in partnership with investment management firm, Baillie Gifford, it enables buy-side firms to gain an independent view o
ZURICH, December 06, 2023--Copresence to share its significant breakthrough in the balance of quality, efficiency, and cost in the digital avatar generation process at CES 2024.
Forty percent of patients who filled a prescription for Novo Nordisk's Wegovy to treat obesity in 2021 or 2022 were still taking it a year later, more than three times the rate of adherence with older medicines, according to an analysis of medical records and insurance claims data. Only 13% of patients who started taking Contrave from Orexigen Therapeutics and 10% of those who started on Qsymia from Vivus between 2015 and 2022 were still filling their prescriptions a year later, researchers reported on Wednesday in the journal Obesity. The findings involved 1,911 adults, 25% of whom received Wegovy, which belongs to a new class of anti-obesity medications known as GLP-1 agonists originally developed to treat type 2 diabetes.
Iran said Wednesday it sent a capsule into orbit carrying animals as it prepares for human missions in coming years. A report by the official IRNA news agency quoted Telecommunications Minister Isa Zarepour as saying the capsule was launched 130 kilometers (80 miles) into orbit. Zarepour said the launch of the 500-kilogram (1,000-pound) capsule is aimed at sending Iranian astronauts to space in coming years.
CHICAGO, December 06, 2023--HYATT STRENGTHENS LUXURY PORTFOLIO WITH 35+ PLANNED HOTELS AND RESORTS TO OPEN THROUGH 2025 IN HIGHLY SOUGHT-AFTER DESTINATIONS ACROSS THE GLOBE
Press Release Nokia and Orange set record with 800Gbps transmission trial on 6,600km Dunant live network to prepare for soaring traffic on strategic trans-Atlantic route Trial utilized Nokia 6th-generation super-coherent Photonic Service Engine (PSE-6), signaling readiness of Nokia 1830 family of optical transport platforms to carry next-gen 800GE IP services as global traffic demand soarsField trial validates Orange network capability on transatlantic submarine cable to support 400GE and 800GE
VIENNA, December 06, 2023--Ribbon Biolabs GmbH, the DNA synthesis company, announced today that its Board of Directors had appointed Jodi Barrientos as interim Chief Executive Officer. Ms. Barrientos, who joined the company this year as Chief Business Officer, brings substantial market experience to Ribbon Biolabs, as it moves forward with its commercialization plan. Founder and former CEO Harold de Vladar, Ph.D., will serve as a senior advisor to the company and member of the Board.
Advanced Airway Clearance Systems Gaining Traction Owing to Rising Prevalence of Chronic Respiratory Diseases GloballyRockville, Dec. 06, 2023 (GLOBE NEWSWIRE) -- As per Fact.MR, a provider of market research and competitive intelligence, the global Airway Clearance System Market is forecasted to reach a value of US$ 1.21 billion by 2034-end, advancing at a noteworthy 6.1% CAGR between 2024 and 2034. Increasing incidence of respiratory disorders, rising awareness of airway clearance therapies, a
WALTHAM, Mass., December 06, 2023--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a 15-year virtual power purchasing agreement (VPPA) with international solar developer ib vogt. Thermo Fisher’s 91-megawatt portion of the Serbal solar project will deliver approximately 192,000 megawatt hours of renewable electricity annually. Eurofins Scientific, a global leader in bioanalytical testing, collaborated in the aggregated deal for a 36-megawatt portion
The Global Newborn Screening Market Size was valued at USD 0.76 Billion in 2022 and the Worldwide Newborn Screening Market Size is expected to reach USD 1.52 Billion by 2032, according to a research report published by Spherical Insights & Consulting. Companies Covered: Bio-Rad Laboratories, Agilent Technologies, Covidien plc, Masimo, Waters Corporation, Natus Medical, Trivitron Healthcare, GE Lifesciences, PerkinElmer Inc., AB SCIEX and other key vendors.New York, United States, Dec. 06, 2023 (
The Global Gene Therapy Market was valued USD 9.42 Billion in 2023 and projected to reach USD 38.33 Billion by 2030, growing at a CAGR of 22.2% during the forecast period of 2023-2030Richmond, Dec. 06, 2023 (GLOBE NEWSWIRE) -- According to a research report "Gene Therapy Market”, By Technology (Viral Vector-Based Gene Therapy {Adeno-Associated Virus (AAV), Lentivirus, Adenovirus, Retrovirus and Modified Herpes Simplex Virus}, Non-Viral Vectors-Based Gene Therapy {Electroporation, Gene Gun, Lipos
06 December 2023 | SAINT HELIER, Jersey - As announced on 07 November 2023, the Board of Directors of CoinShares International Limited ("CoinShares" or the "Company") (Nasdaq Stockholm Market: CS; US OTCQX: CNSRF), Europe's leading alternative asset manager specialising in digital assets, resolved to extend a share buy-back program and repurchase shares on Nasdaq Stockholm Market during the period 07 November 2023, up to and including 30 May 2024 for total maximum amount of SEK 30 million in acc
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on the bright side, you...
Girlfriend Mariah the Scientist reacts to sweater claims in Rico trial
As functional food products become more popular and the cosmetics and food industry expands, the demand for carotenoids will increase.Wilmington, Delaware, United States, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. -The global carotenoids market was valued at US$ 6.2 billion in 2022. A CAGR of 4.5% is forecast between 2023 and 2031. The market is expected to reach US$ 9.0 billion by 2031. Carotenoids are linked to a lower risk of cancer and may benefit other aspects of he
Yahoo Finance